MMS acquires Exploristics and KerusCloud to expand biostatistics and data science capabilities
Acquiring Company
MMS
Acquired Company
Exploristics
BelfastBiotechnologyData And AnalyticsHealth CareBiotechnologyDescription
MMS, a data-focused Contract Research Organization (CRO), has announced the acquisition of Exploristics, a top company in biostatistics and data science based in Belfast, Northern Ireland. This acquisition will enhance MMS's global footprint and capabilities in advanced clinical trial design, innovative statistics, and data science, solidifying its position as a leader in biometric solutions and development strategy for biotech and pharmaceutical sponsors of all sizes.
Quick answer
MMS is acquiring Exploristics, announced February 13, 2025.
- How much did MMS pay for Exploristics?
- The deal value was not disclosed.
- What does MMS do?
- MMS Holdings (MMS) is an award-winning, data-focused clinical research organization (CRO) that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory..
- Where are MMS and Exploristics based?
- Exploristics is based in Belfast, Northern Ireland, United Kingdom.
- Who are the decision-makers at MMS?
- Fundz holds 1 contact at MMS. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Data And Analytics and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- ActiGraph completes acquisition of Biofourmis Connect to enhance digital health solutions (January 7, 2025)
- Curium acquires Monrol to boost Lu-177 capacity (March 28, 2025)
- START acquires Carolina Urologic Research Center (March 18, 2025)
- Gleamer acquires Pixyl and Caerus Medical (March 11, 2025)
- GSK completes acquisition of IDRx, Inc. to enhance precision therapeutics for treating gastrointestinal stromal tumours (February 24, 2025)
- Flourish Research acquires Diablo Clinical Research to expand therapeutic coverage (February 18, 2025)
Who to call at MMS, and when
When MMS changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day MMS raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MMS, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MMS. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MMS makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Exploristics?
Exploristics was acquired by MMS. The deal was reported on February 13, 2025. MMS is privately held and operates in Biotechnology.
When did MMS acquire Exploristics?
MMS's acquisition of Exploristics was reported on February 13, 2025. MMS, a data-focused Contract Research Organization (CRO), has announced the acquisition of Exploristics, a top company in biostatistics and data science based in Belfast, Northern Ireland. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Exploristics do?
Exploristics is a global provider of specialised software products and technology-enabled services to the pharmaceutical, biotechnology, medical diagnostics and devices sector. It is privately held, operating in Biotechnology, and is based in Belfast.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.